The role of human and microbial metabolites of triptophane in severe diseases and critical ill (review)
Автор: Getsina M.L., Chernevskaya E.A., Beloborodova N.V.
Журнал: Клиническая практика @clinpractice
Рубрика: Обзоры
Статья в выпуске: 1 т.11, 2020 года.
Бесплатный доступ
The growing interest to metabolites circulating in the blood is associated with the accumulation of factual material on the involvement of low-molecular compounds in the development of a number of serious diseases. This review reveals the effect of a whole class of chemical compounds - tryptophan metabolites - on various pathological processes. The following keywords were used to find the publications in the PubMed database for the last 10 years: names of natural indole compounds, methods for their detection, nosology of diseases and critical illness . The data are presented in sections, with the studies of tryptophan metabolites in a variety of disease groups, such as cancer, cardiovascular disease, kidney disease, bowel, mental disorders, atherosclerosis, etc. A particular attention is paid to the role of indole compounds that enter the systemic circulation as a result of microbial biotransformation of tryptophan, serotonin and other indole metabolites, which can be attributed to the “common metabolites” of humans and microbiota...
Review, tryptophan, indole metabolites, uremia, colorectal cancer, atherosclerosis, intestinal inflammation, schizophrenia, depressive disorders, metabolic approach, biomarkers, critical ill
Короткий адрес: https://sciup.org/143170837
IDR: 143170837 | DOI: 10.17816/clinpract19068